Protagenic Therapeutics, Inc.\New (PTIXW) SEC Filings — 2025

Filings

• Protagenic Therapeutics Seeks Auditor Ratification Amid Going Concern Doubts — DEF 14A · Dec 5, 2025
• Protagenic's Losses Mount Amid Restructuring, Cash Influx — 10-Q · Nov 26, 2025
• Protagenic Therapeutics Appoints New Directors and CMO — 8-K · Nov 5, 2025
• Protagenic Therapeutics Files 8-K — 8-K · Oct 31, 2025
• Protagenic Therapeutics Files 8-K Amendment — 8-K/A · Sep 17, 2025
• Protagenic Therapeutics Files 8-K/A Amendment — 8-K/A · Aug 28, 2025
• Protagenic Therapeutics Faces Delisting Concerns — 8-K · Aug 22, 2025
• Protagenic Therapeutics Reports Key Corporate Events — 8-K · Aug 13, 2025
• Protagenic Therapeutics Files 8-K — 8-K · Jul 30, 2025
• Protagenic Therapeutics Announces Board and Executive Changes — 8-K · Jul 24, 2025
• Protagenic Therapeutics Files 8-K — 8-K · Jun 27, 2025
• Protagenic Therapeutics Files 8-K — 8-K · May 21, 2025
• Protagenic Therapeutics Files 8-K on Agreements and Equity Sales — 8-K · May 20, 2025
• Protagenic Therapeutics Reports Multiple Material Events — 8-K · May 19, 2025
• Protagenic Therapeutics Files Q1 2025 10-Q — 10-Q · May 13, 2025
• Protagenic Therapeutics Files 8-K — 8-K · May 5, 2025
• Protagenic Therapeutics Files 8-K — 8-K · Apr 29, 2025
• Protagenic Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Apr 18, 2025
• Protagenic Therapeutics Files 2024 10-K — 10-K · Mar 31, 2025
• Protagenic Therapeutics Files Definitive Proxy Statement — DEF 14A · Mar 10, 2025
• Protagenic Therapeutics Files 8-K on Security Holder Vote Matters — 8-K · Feb 24, 2025
• Protagenic Therapeutics Faces Delisting Concerns — 8-K · Jan 29, 2025
• Protagenic Therapeutics Faces Delisting Concerns — 8-K · Jan 16, 2025
• Protagenic Therapeutics Enters Material Definitive Agreement — 8-K · Jan 10, 2025
• Protagenic Therapeutics Files Proxy Materials — DEFA14A · Jan 6, 2025
• Protagenic Therapeutics Files 2025 Proxy Statement — DEF 14A · Jan 3, 2025